Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action.
J Antimicrob Chemother. 2001 Dec;48(6):757-67. doi: 10.1093/jac/48.6.757.
J Antimicrob Chemother. 2001.
PMID: 11733458
Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo.
Weber O, Bender W, Eckenberg P, Goldmann S, Haerter M, Hallenberger S, Henninger K, Reefschläger J, Trappe J, Witt-Laido A, Ruebsamen-Waigmann H.
Weber O, et al. Among authors: ruebsamen waigmann h.
Antiviral Res. 2001 Mar;49(3):179-89. doi: 10.1016/s0166-3542(01)00127-9.
Antiviral Res. 2001.
PMID: 11428244
Item in Clipboard
A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.
Buerger I, Reefschlaeger J, Bender W, Eckenberg P, Popp A, Weber O, Graeper S, Klenk HD, Ruebsamen-Waigmann H, Hallenberger S.
Buerger I, et al. Among authors: ruebsamen waigmann h.
J Virol. 2001 Oct;75(19):9077-86. doi: 10.1128/JVI.75.19.9077-9086.2001.
J Virol. 2001.
PMID: 11533171
Free PMC article.
Item in Clipboard
Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model.
Weber O, Schlemmer KH, Hartmann E, Hagelschuer I, Paessens A, Graef E, Deres K, Goldmann S, Niewoehner U, Stoltefuss J, Haebich D, Ruebsamen-Waigmann H, Wohlfeil S.
Weber O, et al. Among authors: ruebsamen waigmann h.
Antiviral Res. 2002 May;54(2):69-78. doi: 10.1016/s0166-3542(01)00216-9.
Antiviral Res. 2002.
PMID: 12062392
Item in Clipboard
Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease.
Baumeister J, Fischer R, Eckenberg P, Henninger K, Ruebsamen-Waigmann H, Kleymann G.
Baumeister J, et al. Among authors: ruebsamen waigmann h.
Antivir Chem Chemother. 2007;18(1):35-48. doi: 10.1177/095632020701800104.
Antivir Chem Chemother. 2007.
PMID: 17354650
Free article.
Item in Clipboard
Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
Thomson CJ, Power E, Ruebsamen-Waigmann H, Labischinski H.
Thomson CJ, et al. Among authors: ruebsamen waigmann h.
Curr Opin Microbiol. 2004 Oct;7(5):445-50. doi: 10.1016/j.mib.2004.08.009.
Curr Opin Microbiol. 2004.
PMID: 15451498
Review.
Item in Clipboard
Prospects and challenges in anti-infective research and development: new drugs and approaches.
Labischinski H, Ruebsamen-Waigmann H.
Labischinski H, et al. Among authors: ruebsamen waigmann h.
Curr Opin Pharmacol. 2008 Oct;8(5):519-21. doi: 10.1016/j.coph.2008.09.006. Epub 2008 Oct 17.
Curr Opin Pharmacol. 2008.
PMID: 18848903
No abstract available.
Item in Clipboard
Cite
Cite